drug protocol number

CS-CTP-AD5NCOV-ⅢCo

drug sponsor

MOH / CanSino

drug study

Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)

drug trial site

King Fahad Medical City (Riyadh)

drug status

Rejected

drug phase